Sagimet Biosciences Inc. Contracts & Agreements
57 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (3)
- Human Resources (31)
- Intellectual Property (2)
- Real Estate (2)
- Uncategorized (4)
- Amended and Restated Sagimet Biosciences Inc. Employee Stock Purchase Plan (Filed With SEC on August 14, 2024)
- Amended and Restated Executive Employment Agreement by and between Sagimet Biosciences Inc. and Elizabeth Rozek, dated June 5, 2024 (Filed With SEC on August 14, 2024)
- Amended and Restated Executive Employment Agreement by and between Sagimet Biosciences Inc. and Eduardo Bruno Martins, M.D., D.Phil., dated June 5, 2024 (Filed With SEC on August 14, 2024)
- Amended and Restated Executive Employment Agreement by and between Sagimet Biosciences Inc. and George Kemble, Ph.D, dated June 5, 2024 (Filed With SEC on August 14, 2024)
- Amended and Restated Executive Employment Agreement by and between Sagimet Biosciences Inc. and David Happel, dated June 5, 2024 (Filed With SEC on August 14, 2024)
- Executive Employment Agreement by and between Sagimet Biosciences Inc. and Thierry Chauche, dated May 6, 2024 (Filed With SEC on August 14, 2024)
- Description of Capital Stock (Filed With SEC on March 25, 2024)
- Amended and Restated Warrant to Purchase Stock, by and between the Registrant and Banc of California, Inc., dated January 4, 2024 (Filed With SEC on January 23, 2024)
- Form of Underwriting Agreement (Filed With SEC on January 23, 2024)
- Executive Employment Agreement by and between the Company and David Happel, dated August 15, 2023 (Filed With SEC on August 21, 2023)
- Executive Employment Agreement by and between the Company and George Kemble, dated August 15, 2023 (Filed With SEC on August 21, 2023)
- Executive Employment Agreement by and between the Company and Eduardo Martins, dated August 15, 2023 (Filed With SEC on August 21, 2023)
- Executive Employment Agreement by and between the Company and Elizabeth Rozek, dated August 15, 2023 (Filed With SEC on August 21, 2023)
- Executive Employment Agreement by and between the Company and Anthony Rimac, dated August 15, 2023 (Filed With SEC on August 21, 2023)
- Assignment and Assumption Agreement, by and among the Registrant, Ascletis BioScience Co., Ltd. and Gannex Pharma Co., Ltd., effective October 25, 2019 (Filed With SEC on July 10, 2023)
- Amended and Restated Patent Assignment Agreement by and between the Registrant and Gannex Pharma Co., Ltd., dated July 2, 2023 (Filed With SEC on July 10, 2023)
- Sagimet Biosciences Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on July 10, 2023)
- Sagimet Biosciences Inc. 2023 Stock Option and Incentive Plan (Filed With SEC on July 10, 2023)
- Form of Underwriting Agreement (Filed With SEC on July 3, 2023)
- Amended and Restated Patent Assignment Agreement by and between the Registrant and Gannex Pharma Co., Ltd., dated July 2, 2023 (Filed With SEC on July 3, 2023)
- Executive Employment Agreement with Elizabeth Rozek, dated April 4, 2023 (Filed With SEC on June 23, 2023)
- Warrant to Purchase Stock, by and between the Registrant and Square 1 Bank, dated April 10, 2015 (Filed With SEC on June 23, 2023)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated December 21, 2020 (Filed With SEC on June 23, 2023)
- Amended and Restated Nominating Agreement, dated as of April 15, 2021, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P. as amended by Amendment No. 1... (Filed With SEC on June 23, 2023)
- Lease Agreement by and between the Registrant and Casiopea Bovet, LLC, dated as of March 1, 2019, as amended by the First Amendment to Lease Agreement, dated December 14, 2021 (Filed With SEC on June 23, 2023)
- Patent Assignment Agreement by and between the Registrant and Gannex Pharma Co., Ltd (Filed With SEC on June 23, 2023)
- Exclusive License and Development Agreement by and between the Registrant and Ascletis BioScience Co. Ltd., dated as of January 18, 2019 (Filed With SEC on June 23, 2023)
- Sagimet Biosciences Inc. Senior Executive Cash Incentive Bonus Plan (Filed With SEC on June 23, 2023)
- Form of Executive Officer Employment Agreement (Filed With SEC on June 23, 2023)
- Executive Employment Agreement with Anthony Rimac, dated April 4, 2023 (Filed With SEC on June 23, 2023)
- 2007 Equity Incentive Plan (Filed With SEC on June 23, 2023)
- Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the 2007 Equity Incentive Plan (Filed With SEC on June 23, 2023)
- Sagimet Biosciences Inc. 2017 Equity Incentive Plan (Filed With SEC on June 23, 2023)
- Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Sagimet Biosciences Inc. 2017 Equity Incentive Plan (Filed With SEC on June 23, 2023)
- Sagimet Biosciences Inc. 2023 Stock Option and Incentive Plan (Filed With SEC on June 23, 2023)
- Forms of Incentive Stock Option Agreement, Non-Qualified Stock Option Agreement for Non-Employee Directors and Non-Qualified Stock Option Agreement for Company Employees under the... (Filed With SEC on June 23, 2023)
- Forms of Restricted Stock Unit Award Agreement for Non-Employee Directors and Restricted Stock Unit Award Agreement for Company Employees under the Sagimet Biosciences Inc. 2023... (Filed With SEC on June 23, 2023)
- Form of Restricted Stock Award Agreement under the Sagimet Biosciences Inc. 2023 Stock Option and Incentive Plan (Filed With SEC on June 23, 2023)
- Sagimet Biosciences Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on June 23, 2023)
- Form of Indemnification Agreement by and between the Registrant and its directors (Filed With SEC on June 23, 2023)
- Form of Indemnification Agreement by and between the Registrant and its executive officers (Filed With SEC on June 23, 2023)
- Offer Letter with Dave Happel, dated October 3, 2022 (Filed With SEC on June 23, 2023)
- Amended and Restated Executive Employment Agreement with Dennis Hom, dated January 11, 2019 (Filed With SEC on June 23, 2023)
- Transition Services Agreement with Dennis Hom, dated April 4, 2023 (Filed With SEC on June 23, 2023)
- Amendment to Transition Services Agreement with Dennis Hom, dated June 18, 2023 (Filed With SEC on June 23, 2023)
- Offer Letter with Eduardo Bruno Martins, M.D., D.Phil., dated February 9, 2021 (Filed With SEC on June 23, 2023)
- Sagimet Biosciences Inc. 2023 Non-Employee Director Compensation Policy (Filed With SEC on June 23, 2023)
- 2007 Equity Incentive Plan (Filed With SEC on April 16, 2021)
- Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the 2007 Equity Incentive Plan (Filed With SEC on April 16, 2021)
- Sagimet Biosciences Inc. 2017 Equity Incentive Plan (Filed With SEC on April 16, 2021)
- Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Sagimet Biosciences Inc. 2017 Equity Incentive Plan (Filed With SEC on April 16, 2021)
- Form of Indemnification Agreement by and between the Registrant and its directors and executive officers (Filed With SEC on April 16, 2021)
- Exclusive License and Development Agreement by and between the Registrant and Ascletis BioScience Co. Ltd., dated as of January 18, 2019 (Filed With SEC on April 16, 2021)
- Patent Assignment Agreement by and between the Registrant and Gannex Pharma Co., Ltd., dated as of October 25, 2019 (Filed With SEC on April 16, 2021)
- Lease Agreement by and between the Registrant and Casiopea Bovet, LLC, dated as of March 1, 2019 (Filed With SEC on April 16, 2021)
- Amended and Restated Nominating Agreement, dated as of April 15, 2021, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P (Filed With SEC on April 16, 2021)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated December 21, 2020 (Filed With SEC on April 16, 2021)
